Loading...
mGluR4-positive allosteric modulation as potential treatment for Parkinson’s disease
Although Parkinson’s disease was first diagnosed nearly 200 years ago, its effective treatment still remains elusive for most of those diagnosed. The gold standard of treatment for most patients is 3,4-dihydroxy-l-phenylalanine. This drug works for most individuals early in the disease; however, res...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2009
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2790174/ https://ncbi.nlm.nih.gov/pubmed/20161443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fmc.09.38 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|